Cipla to acquire US-based InvaGen Pharmaceuticals and Exelan Pharmaceuticals Sanjiv Das Sep 4, 2015 Signs agreements to acquire 100 per cent of generic businesses in the US for $550 million Cipla's UK arm, Cipla EU has entered…
